Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Lancet. Infectious Diseases|March 3, 2023
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statementJosé Domínguez, Martin J Boeree, Emmanuelle Cambau, et al.Trials|March 23, 2023
Strengthening primary care for diabetes and hypertension in Eswatini: study protocol for a nationwide cluster-randomized controlled trialMichaela Theilmann, Ntombifuthi Ginindza, John Myeni, et al.The European Respiratory Journal|February 12, 2021
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic modelJan Heyckendorf, Sebastian Marwitz, Maja Reimann, et al.Eclinicalmedicine|January 13, 2023
Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysisYohhei Hamada, Rishi K Gupta, Matteo Quartagno, et al.Nature Medicine|October 20, 2020
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settingsRishi K Gupta, Claire J Calderwood, Alexei Yavlinsky, et al.Plos One|February 6, 2020
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trialsKoukeo Phommasone, Frank van Leth, Thomas J Peto, et al.The Journal of Infection|December 22, 2025
Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort studyBerit Lange, Thomas Theo Brehm, Sandra M Arend, et al.The European Respiratory Journal|March 25, 2014
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statementChristoph Lange, Ibrahim Abubakar, Jan-Willem C Alffenaar, et al.The Lancet Regional Health. Europe|December 16, 2025
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310Martina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.The Lancet Regional Health. Europe|August 18, 2025
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyMartina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.Pageof 9